Their findings showed that the T2 enhancement ratio and ΔR2 values could semi-quantitatively assess CXCR4 expression in four pancreatic cancer cell lines (AsPC-1, BxPC-3, CFPAC-1, and PANC-1), potentially serving as prognostic indicators [33]. This evidence concerns the gene CXCR4 and pancreatic neoplasm.